tirzepatide lilly direct Eli Lilly, Maker of Mounjaro and Zepbound, Wades Into Telehealth Lilly launches lower-price weight-loss drug

Improved Glycemic Control: It helps manage blood sugar levels effectively, making it a strong option for people with type 2 diabetes

30-40M American adults have used a GLP-1 medication for weight loss 2/3 of weight lost is regained within a year of stopping medication 40% of weight lost on GLP-1s can be muscle, not fat - without proper nutrition support Free resources to get started No signup required

Protecting hydration, fiber intake, and protein helps reduce autonomic stress and makes pulse control easier

Hypoglycemia in Patients with Diabetes and Renal Disease

Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): A placebo-controlled, randomised, phase 3a trial

doi: 10.2174/09298673113209990181